This inventor holds 2 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2017-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2018
Title: Vasamsetti Sathish Babu: Innovator in Antioxidant Research
Introduction
Vasamsetti Sathish Babu is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of antioxidant research, particularly in developing compounds that have potential health benefits. With a total of 2 patents to his name, his work is paving the way for advancements in medical science.
Latest Patents
One of his latest patents is titled "Antioxidant compound having anti atherosclerotic effect and preparation thereof." This invention focuses on the synthesis of TPP+ coupled esculetin, also known as mitochondria-targeted esculetin (Mito-Esc). The biological evaluation of Mito-Esc demonstrates its ability to attenuate Angiotensin-II-induced atherosclerosis in apolipoprotein E knockout mice. Additionally, it highlights the endothelial cell age-delaying effects of Mito-Esc, showcasing its potential in combating age-related vascular issues.
Career Highlights
Vasamsetti Sathish Babu is associated with the Council of Scientific and Industrial Research, where he conducts his research and development activities. His work is characterized by a strong focus on innovative solutions to health-related challenges, particularly those associated with oxidative stress and cardiovascular diseases.
Collaborations
He collaborates with esteemed colleagues such as Karnewar Santosh and Kotamraju Srigiridhar, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Vasamsetti Sathish Babu's contributions to antioxidant research are significant and impactful. His innovative patents and collaborative efforts are essential in advancing our understanding of health and disease management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
